Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL study. Schmermund, A.; Mohlenkamp, S.; Stang, A.; Gronemeyer, D.; Seibel, R.; Hirche, H.; Mann, K.; Siffert, W.; Lauterbach, K.; Siegrist, J.; Jockel, K.; and Erbel, R. American Heart Journal, 144(2):212-218, 2002.
bibtex   
@Article{Schmermund_2002_7611,
  author = {Schmermund, A. and Mohlenkamp, S. and Stang, A. and Gronemeyer, D. and Seibel, R. and Hirche, H. and Mann, K. and Siffert, W. and Lauterbach, K. and Siegrist, J. and Jockel, K.-H. and Erbel, R.},
 journal = {American Heart Journal},
 number = {2},
 pages = {212-218},
 title = {Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: {R}ationale and design of the {H}einz {N}ixdorf {RECALL} study},
 volume = {144},
 year = {2002},
 title_with_no_special_chars = {Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middleaged subjects Rationale and design of the Heinz Nixdorf RECALL study}
}
Downloads: 0